Skip to main content
×
×
Home

Injectable heroin – effective treatment for opiate misusers, but is it cost-effective?

  • Rachael M. Hunter (a1) and Sherife Hasan (a2)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Injectable heroin – effective treatment for opiate misusers, but is it cost-effective?
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Injectable heroin – effective treatment for opiate misusers, but is it cost-effective?
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Injectable heroin – effective treatment for opiate misusers, but is it cost-effective?
      Available formats
      ×
Abstract
Copyright
Corresponding author
Miss Rachael M. Hunter, Department of Primary Care and Population Sciences, University College London Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. Email: r.hunter@ucl.ac.uk
Footnotes
Hide All

See pp. 341–349, this issue.

Footnotes
References
Hide All
1 Strang, J., Babor, T., Caulkins, J., Fischer, B., Foxcroft, D., Humphreys, K. Drug policy and the public good: evidence for effective interventions. Lancet 2012; 379: 7183.
2 Byford, S., Barrett, B., Metrebian, N., Groshkova, T., Cary, M., Charles, V., et al Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Br J Psychiatry 2013; 203: 341–9.
3 Davies, C., English, L., Stewart, C., Edginton, M., McVeigh, J., Bellis, M A. United Kingdom Drug Situation: 2012 Edition. UK Focal Point on Drugs: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Department of Health, 2012.
4 Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., et al Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011; 106: 3251.
5 Weich, S., McBride, O., Hussey, D., Exeter, D., Brugha, T., McManus, S. Latent class analysis of co-morbidity in the Adult Psychiatric Morbidity Survey in England 2007: implications for DSM-5 and ICD-11. Psychol Med 2011; 41: 2201–12.
6 Pouget, ER, Hagan, H., Des Jarlais, DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction 2012; 107: 1057–65.
7 Bröning, S., Kumpfer, K., Kruse, K., Sack, P., Schaunig-Busch, I., Ruths, S., et al Selective prevention programs for children from substance-affected families: a comprehensive systematic review. Subst Abuse Treat Prev Policy 2012; 7: 23.
8 Sneader, W. The discovery of heroin. Lancet 1998; 352: 1697–99.
9 Strang, J., Metrebian, N., Lintzeris, N., Potts, L., Carnwath, T., Mayet, S., et al Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet 2010; 375: 1885–95.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 24 *
Loading metrics...

Abstract views

Total abstract views: 120 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 13th June 2018. This data will be updated every 24 hours.

Injectable heroin – effective treatment for opiate misusers, but is it cost-effective?

  • Rachael M. Hunter (a1) and Sherife Hasan (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *